You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

Mechanism of Action: Ammonium Ion Binding Activity


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Mechanism of Action: Ammonium Ion Binding Activity

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Endo Operations SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 203918-001 Jun 15, 2016 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Endo Operations SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 204395-001 Apr 15, 2016 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Glenmark Pharms Ltd SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 216462-001 Nov 1, 2022 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Sigmapharm Labs Llc SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 202819-001 Mar 22, 2013 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries

Ammonium Ion Binding Activity Market Analysis and Financial Projection

The pharmaceutical market surrounding drugs with ammonium ion binding activity is shaped by a combination of emerging therapeutic applications, agricultural demand, and evolving patent strategies. Here's a detailed analysis of the current landscape:

Market Dynamics

Agricultural Demand Drives Ammonium Innovation
Ammonium compounds are integral to fertilizer production, with 37.79% of global ammonia market revenue in 2023 originating from North America[3]. This agricultural reliance creates cross-industry opportunities, as improved ammonium ion binding technologies (like crown ether-based ionophores) developed for crop science often find pharmaceutical applications[1][10].

Pharmaceutical Expansion
Key growth areas include:

  • Respiratory Treatments: Ammonium carbonate’s use in cough syrups and expectorants benefits from rising global respiratory health needs[9]
  • Neurological Disorders: Patent activity reveals interest in targets like D-amino acid oxidase (DAO), where ammonium-binding compounds could modulate psychotic disorders[6]
  • Diagnostic Tools: Advanced ionophores like US6746595B2 enable precise ammonium detection in medical sensors[8]

The global ammonia market is projected to reach $172.77B by 2033 (6.3% CAGR), driven partly by pharmaceutical applications in drug stabilization and vaccine production[3].

Patent Landscape

Key Patent Strategies

  1. Therapeutic Formulations

    • EP3954994A1: Combines Berthelot reaction components for rapid ammonium detection in biological samples[5]
    • US8840934: Uses NH4Cl dosage forms to stimulate endogenous interferon production[2]
  2. Agricultural Synergies
    Patents like US8889592 demonstrate how crop protection ammonium salt formulations (e.g., spiroheterocyclic compounds) often include pharma-relevant binding mechanisms[2][8].

  3. Targeted Binding Innovations
    Recent advances include:

    • Solid-state NMR detection of ammonium channel binding (JACS 2022)[7]
    • Thiazole-containing crown ether derivatives showing 73× NH4+/K+ selectivity over nonactin[1][10]

Challenges vs Opportunities

Factor Challenge Opportunity
Selectivity Competing cations (Na+/K+) reduce efficacy Novel crown ether designs achieve log K > -3.5 vs Na+[1]
Formulation Stability Hygroscopic base degradation Dichloroisocyanurate stabilizers in EP3954994A1[5]
Therapeutic Scope Limited CNS penetration RET proto-oncogene targeting shows 886 patent filings[6]

Emerging Trends

  • Green Chemistry: Bio-based ammonium carbonate production grows at 5.1% CAGR[9]
  • Precision Medicine: AmTrac sensors enable real-time ammonium transport monitoring[4]
  • Rare Diseases: 42.4% patent focus on North America reflects targeted therapy development[6][9]

"The molecular recognition of ammonium ions through hydrogen bonding and cation-π interactions enables both agricultural and pharmaceutical applications" [10].

While substitutes like ammonium nitrate pressure market margins, patents on ion-selective matrices and sustainable production methods suggest continued innovation. The convergence of advanced detection technologies (NMR sensors[7]), synthetic receptor design[1][10], and cross-industry patent strategies positions ammonium ion binding as a growth area in both small-molecule therapies and diagnostic tools.

References

  1. https://www.beilstein-journals.org/bjoc/articles/6/32
  2. https://patents.justia.com/patents-by-us-classification/424/720
  3. https://www.globenewswire.com/news-release/2024/10/25/2969401/0/en/Ammonia-Market-Size-to-Hit-Around-USD-172-77-Billion-by-2033.html
  4. https://elifesciences.org/articles/01029
  5. https://patents.google.com/patent/EP3954994A1/en
  6. https://www.biorxiv.org/content/10.1101/2023.02.10.527980v3.full-text
  7. https://pubs.acs.org/doi/10.1021/jacs.1c13247
  8. https://patents.google.com/patent/US6746595B2/en
  9. https://www.news.market.us/ammonium-carbonate-market-news/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC2874414/
  11. https://www.businesswire.com/news/home/20211013005557/en/Worldwide-Ammonium-Sulfate-Industry-to-2026---by-Form-End-user-and-Region---ResearchAndMarkets.com
  12. https://www.diva-portal.org/smash/get/diva2:1480779/FULLTEXT01.pdf

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.